AMGN compared with TARS: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

TARSTarsus Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

TARSTarsus Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only TARS 6

ELANElanco Tiergesundheitsupplier

—Elancounlistedsupplier

—LianBio Ophthalmologyunlistedcustomer

—

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Xi An Grand Chang An Pharmaceutical

unlistedcustomer

2 more · TARS chain ›

AMGNAmgen Inc

461.49· pre 450.75· delayed

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

TARSTarsus Pharmaceuticals, Inc.

67.46· pre 66.23· delayed

Pre-marketNov 6 '26delayed

Mkt cap$3.4BRevenue$195MQ3 FY26Revenue$451MFY25

Compare

Pre-marketNov 6 '26delayed

AMGNAmgen Inc

TARSTarsus Pharmaceuticals, Inc.

461.49pre 450.75delayed

Price

67.46pre 66.23delayed

$249.0B

Mkt cap

$3.4B

Q3 FY26$10.4B

Revenue

$195MQ3 FY26

FY25$36.8B

Revenue

$451MFY25

AMGN461.49vsTARS67.46Pre-marketNov 6 '26delayed